Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1991
(+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonistK D Burris, M Breeding, E Sanders-Bush
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1988
Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysisE Sanders-Bush, K D Burris, K Knoth
Psychopharmacology|January 1, 1983
Additional evidence that L-5-hydroxytryptophan discrimination models a unique serotonin receptorR Friedman, R J Barrett, E Sanders-Bush
European Journal of Pharmacology|December 17, 1981
Multiple serotonin receptors: regional distribution and effect of Raphe lesionsM A Blackshear, L R Steranka, E Sanders-Bush
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1990
Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behaviorR L Smith, R J Barrett, E Sanders-Bush
Psychopharmacology|January 1, 1989
Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling systemE Sanders-Bush, M Breeding, K Knoth, et al.
Science'S STKE : Signal Transduction Knowledge Environment|December 26, 2001
Dissecting intracellular signaling pathways with membrane-permeable peptidesM S Chang, J P Tam, E Sanders-Bush
Brain Research|June 28, 1991
Phosphoinositide hydrolysis linked 5-HT2 receptors in fibroblasts from choroid plexusE L Barker, K D Burris, E Sanders-Bush
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1984
Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sitesR L Friedman, R J Barrett, E Sanders-Bush
Pageof 17